Coloplast A/S (CLPBY)
Coloplast Market Cap: 20.25B for Jan. 12, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Novo Nordisk A/S | 265.99B |
| Genmab A/S | 20.88B |
| Ascendis Pharma A/S | 12.75B |
| Evaxion AS | 32.72M |
| IO Biotech, Inc. | 36.41M |
Market Cap Related Metrics
| PE Ratio | 37.68 |
| PS Ratio | 4.904 |
| Price to Book Value | 8.674 |
| Price to Free Cash Flow | 26.07 |
| Price | 8.988 |
| Earnings Yield | 2.65% |
| Operating PE Ratio | 18.03 |
| Normalized PE Ratio | 34.25 |